-transparent.png){kind=logo}
The hemodynamic effects of doxaminol, a new, orally applicable beta-agonist, chemically dissimilar to catecholamines, were studied in comparison to those of dobutamine by means of thermodilution. After single-dose application of doxaminol in cases of congestive heart failure, cardiac output and stroke volume increased, heart rate increased slightly, pulmonary and systemic arterial pressure remained constant, and peripheral vascular resistance decreased. No arrhythmias appeared, but one patient suffered an attack of angina.
Related Publications
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
January 1993,
Coronary artery disease,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
January 1986,
Indian heart journal,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
August 1986,
The New England journal of medicine,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
March 1987,
Kokyu to junkan. Respiration & circulation,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
February 1986,
Arzneimittel-Forschung,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
January 1987,
Progress in cardiovascular nursing,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
May 1988,
Cardiovascular drugs and therapy,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
January 1985,
The American journal of cardiology,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
March 1983,
The American journal of cardiology,
K Bödigheimer, and
T Ischinger, and
F G Nowak, and
W Delius
May 1987,
Circulation,
